Literature DB >> 20921227

Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease.

Ayisha Siddiqua1, Martin Margittai.   

Abstract

Tau filaments are the pathological hallmark of numerous neurodegenerative diseases including Alzheimer disease, Pick disease, and progressive supranuclear palsy. In the adult human brain, six isoforms are expressed that differ by the presence or absence of the second of four semiconserved repeats. As a consequence, half of the tau isoforms have three repeats (3R tau), whereas the other half of the isoforms have four repeats (4R tau). Tauopathies can be characterized based on the isoform composition of their filaments. Alzheimer disease filamentous inclusions contain all isoforms. Pick disease filaments contain 3R tau. Progressive supranuclear palsy filaments contain 4R tau. Here, we used site-directed spin labeling of recombinant tau in conjunction with electron paramagnetic resonance spectroscopy to obtain structural insights into these filaments. We find that filaments of 4R tau and 3R tau share a highly ordered core structure in the third repeat with parallel, in-register arrangement of β-strands. This structure is conserved regardless of whether full-length isoforms (htau40 and htau23) or truncated constructs (K18 and K19) are used. When mixed, 3R tau and 4R tau coassemble into heterogeneous filaments. These filaments share the highly ordered core in the third repeat; however, they differ in their overall composition. Our findings indicate that at least three distinct types of filaments exist: homogeneous 3R tau, homogeneous 4R tau, and heterogeneous 3R/4R tau. These results suggest that individual filaments found in Alzheimer disease are structurally distinct from those in the 3R and 4R tauopathies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921227      PMCID: PMC2988394          DOI: 10.1074/jbc.M110.185728

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Neurodegenerative tauopathies.

Authors:  V M Lee; M Goedert; J Q Trojanowski
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 2.  Identifying conformational changes with site-directed spin labeling.

Authors:  W L Hubbell; D S Cafiso; C Altenbach
Journal:  Nat Struct Biol       Date:  2000-09

3.  Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Authors:  P Poorkaj; T D Bird; E Wijsman; E Nemens; R M Garruto; L Anderson; A Andreadis; W C Wiederholt; M Raskind; G D Schellenberg
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

Review 4.  The structure of amyloid fibrils by electron microscopy and X-ray diffraction.

Authors:  M Sunde; C Blake
Journal:  Adv Protein Chem       Date:  1997

5.  Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated.

Authors:  Ravindra Kodali; Angela D Williams; Saketh Chemuru; Ronald Wetzel
Journal:  J Mol Biol       Date:  2010-06-18       Impact factor: 5.469

6.  Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.

Authors:  G C Telling; P Parchi; S J DeArmond; P Cortelli; P Montagna; R Gabizon; J Mastrianni; E Lugaresi; P Gambetti; S B Prusiner
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

7.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.

Authors:  M Goedert; R Jakes; M G Spillantini; M Hasegawa; M J Smith; R A Crowther
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

8.  Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.

Authors:  M Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; A Grover; J Hackett; J Adamson; S Lincoln; D Dickson; P Davies; R C Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; J C Morris; L A Reed; J Trojanowski; H Basun; L Lannfelt; M Neystat; S Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; D Neary; F Owen; B A Oostra; J Hardy; A Goate; J van Swieten; D Mann; T Lynch; P Heutink
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

Review 9.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  29 in total

1.  Tau isoform composition influences rate and extent of filament formation.

Authors:  Qi Zhong; Erin E Congdon; Haikady N Nagaraja; Jeff Kuret
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

2.  Alternative conformations of the Tau repeat domain in complex with an engineered binding protein.

Authors:  Clara S R Grüning; Ewa A Mirecka; Antonia N Klein; Eckhard Mandelkow; Dieter Willbold; Stephen F Marino; Matthias Stoldt; Wolfgang Hoyer
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

3.  Single mutations in tau modulate the populations of fibril conformers through seed selection.

Authors:  Virginia Meyer; Paul D Dinkel; Yin Luo; Xiang Yu; Guanghong Wei; Jie Zheng; Gareth R Eaton; Buyong Ma; Ruth Nussinov; Sandra S Eaton; Martin Margittai
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-22       Impact factor: 15.336

4.  Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.

Authors:  Toshiki Uchihara; Makoto Hara; Ayako Nakamura; Katsuiku Hirokawa
Journal:  Histochem Cell Biol       Date:  2011-11-25       Impact factor: 4.304

Review 5.  Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.

Authors:  Thimmappa S Anekonda; Joseph F Quinn
Journal:  Biochim Biophys Acta       Date:  2011-09-08

6.  How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Authors:  Liang Xu; Jie Zheng; Martin Margittai; Ruth Nussinov; Buyong Ma
Journal:  ACS Chem Neurosci       Date:  2016-02-24       Impact factor: 4.418

7.  Revealing Conformational Variants of Solution-Phase Intrinsically Disordered Tau Protein at the Single-Molecule Level.

Authors:  Lydia H Manger; Alexander K Foote; Sharla L Wood; Michael R Holden; Kevin D Heylman; Martin Margittai; Randall H Goldsmith
Journal:  Angew Chem Int Ed Engl       Date:  2017-11-14       Impact factor: 15.336

Review 8.  Potential mechanisms and implications for the formation of tau oligomeric strains.

Authors:  Julia E Gerson; Amrit Mudher; Rakez Kayed
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

9.  Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.

Authors:  Hilary A Weismiller; Rachel Murphy; Guanghong Wei; Buyong Ma; Ruth Nussinov; Martin Margittai
Journal:  J Biol Chem       Date:  2018-09-21       Impact factor: 5.157

10.  Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons.

Authors:  Jessica W Wu; Mathieu Herman; Li Liu; Sabrina Simoes; Christopher M Acker; Helen Figueroa; Joshua I Steinberg; Martin Margittai; Rakez Kayed; Chiara Zurzolo; Gilbert Di Paolo; Karen E Duff
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.